ResMed (RMD) : Thursdays money flow data in ResMed (RMD) suggests that the bulls made the most of the weakness in the stock. The inflow of money into the stock on upticks was $12.5 million, whereas, $6.86 million worth of transactions were done on downticks. The ratio between the two, uptick and downtick stood at 1.82, in favor of the bulls. The total money flow into the stock was $5.64 million clearly indicating that the smart money has been buying into the stock on weakness.
In comparison, the money flow in block deals was $5.72 million. The total value of block trades done on upticks was $5.72 million. ResMed (RMD) fell $0.56 and traded at $63.35, down -0.88% for the day, over previous days close. On a weekly basis, the shares are -0.28% over the previous weeks close.
ResMed (RMD) : 7 investment research analysts covering ResMed (RMD) have an average price target of $56.2 for the near short term. The highest target price given by the Brokerage Firm to the stock is $64 and the lowest target is $44 for the short term. Analysts expect the variance to be within $6.24 of the average price. The stock has recorded a 20-day Moving Average of 3.87% and the 50-Day Moving Average is 7.49%.
ResMed (NYSE:RMD): The stock opened at $63.59 on Thursday but the bulls could not build on the opening and the stock topped out at $63.93 for the day. The stock traded down to $63.28 during the day, due to lack of any buying support eventually closed down at $63.35 with a loss of -0.88% for the day. The stock had closed at $63.91 on the previous day. The total traded volume was 704,876 shares.
ResMed Inc. is engaged in the development, manufacturing, distribution and marketing of medical products for the diagnosis, treatment and management of respiratory disorders, with a focus on sleep-disordered breathing (SDB). The Company develops various products for SDB and other respiratory disorders, including airflow generators, diagnostic products, mask systems, headgear and other accessories. It produces continuous positive airway pressure, variable positive airway pressure and AutoSet systems for the titration and treatment of SDB. Its products also include S9 Escape, AirSense 10 Elite, AirSense 10 CPAP, S9 VPAP S, S9 VPAP ST, S9 VPAP Adapt, S9 VPAP ST-A, S9 VPAP COPD and AirCurve 10 V Auto, among others. It markets sleep recorders for the diagnosis and titration of SDB in sleep clinics and hospitals. Its products include Quattro FX, Swift FX for Her, Mirage FX for Her, Pixi Pediatric Mask, Quattro FX for Her, Swift FX Bella, Swift FX Nano, AirFit N10 and Apnealink Air.